Omalizumab chronic spontaneous urticaria: efficacy, safety, predictors of treatment outcome and time to response
Chronic spontaneous urticaria (CSU) is the most common subtype of urticaria, and is characterized by recurrent episodes of spontaneous wheals and/or angioedema with unknown triggers, lasting for more than six weeks.1 CSU generally affects 0.5 –1.0% of people 20–40 years of age, with a disease duration of 1–5 years.2 Patients with CSU often experience sleep deprivation and psychiatric comorbidities like anxiety and depression, which compromise the health-related and overall quality of life of the affected individuals.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: E. Nettis, L. Cegolon, E. Di Leo, F. Lodi Rizzini, A. Detoraki, W.G. Canonica, Italian OCUReL study group Source Type: research
More News: Allergy | Allergy & Immunology | Anxiety | Asthma | Depression | Hives | Italy Health | Psychiatry | Sleep Disorders | Sleep Medicine | Study | Xolair